A point-mutation in codon 12 of KRAS was evaluated with RAS-specific DNA sequencing, which confirmed that the presence of a KRAS point-mutation in lung cancer indicated a poor prognosis and shorter DFS [233]. This evidence concerns the gene KRAS and lung cancer.